肿瘤微生物群落分析识别结直肠癌的临床分子与预后亚型
对423例I至IV期结直肠癌患者的肿瘤和正常黏膜进行细菌16S rRNA基因测序,肿瘤可重复分为3种肿瘤微生物群落亚型(OCS1、OCS2、OCS3),各亚型具有不同的临床分子特征和预后;在293例II/III期肿瘤独立队列中验证了微生物聚类。
要点
- 结直肠癌组织可分为3种肿瘤微生物群落亚型:OCS1(梭杆菌/口腔病原体,蛋白水解,21%)、OCS2(厚壁菌门/拟杆菌门,糖水解,44%)、OCS3(埃希菌/假埃希菌/志贺菌,脂肪酸β氧化,35%)。
- OCS1多见于右侧、高级别、MSI-high、CIMP阳性、CMS1、BRAF V600E和FBXW7突变;OCS2和OCS3多见于左侧并显示CIN。
- 在II/III期微卫星稳定肿瘤中,OCS1和OCS3的总生存均劣于OCS2(多因素HR分别为1.85和1.52);在左侧肿瘤中同样劣于OCS2(HR分别为2.66和1.76)。
核心结论
- OCS分类将结直肠癌分为3个具有不同临床分子特征和结局的亚组,为基于微生物群的结直肠癌分层提供了框架,以改进预后判断并为微生物群靶向干预的开发提供信息。
研究设计与样本
- 对423例I至IV期结直肠癌患者的肿瘤和正常黏膜进行细菌16S rRNA基因测序,并检测MSI、CIMP、APC、BRAF、KRAS、PIK3CA、FBXW7、SMAD4、TP53突变,部分样本检测CIN、突变特征和CMS;微生物聚类在293例II/III期肿瘤独立队列中验证。
主要发现
- 肿瘤可重复分层为3种肿瘤微生物群落亚型(OCS):OCS1(梭杆菌/口腔病原体,蛋白水解,21%)多见于右侧、高级别、MSI-high、CIMP阳性、CMS1、BRAF V600E和FBXW7突变;OCS2(厚壁菌门/拟杆菌门,糖水解,44%)和OCS3(埃希菌/假埃希菌/志贺菌,脂肪酸β氧化,35%)多见于左侧并显示CIN。
- OCS1与MSI相关突变特征(SBS15、SBS20、ID2和ID7)相关,OCS2和OCS3与活性氧损伤相关的SBS18相关。
- 在II/III期微卫星稳定肿瘤中,OCS1和OCS3的总生存均劣于OCS2(多因素HR 1.85,95%CI 1.15-2.99,P=0.012;HR 1.52,95%CI 1.01-2.29,P=0.044)。
- 在II/III期左侧肿瘤中,OCS1和OCS3的总生存均劣于OCS2(多因素HR 2.66,95%CI 1.45-4.86,P=0.002;HR 1.76,95%CI 1.03-3.02,P=0.039)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Dysbiosis of gut microbiota is linked to the development of colorectal cancer (CRC). However, microbiota-based stratification of CRC tissue and how this relates to clinicomolecular characteristics and prognosis remains to be clarified. METHODS: Tumor and normal mucosa from 423 patients with stage I to IV CRC were profiled by bacterial 16S rRNA gene sequencing. Tumors were characterized for microsatellite instability (MSI), CpG island methylator phenotype (CIMP), APC, BRAF, KRAS, PIK3CA, FBXW7, SMAD4, and TP53 mutations, subsets for chromosome instability (CIN), mutation signatures, and consensus molecular subtypes (CMS). Microbial clusters were validated in an independent cohort of 293 stage II/III tumors. RESULTS: Tumors reproducibly stratified into 3 oncomicrobial community subtypes (OCSs) with distinguishing features: OCS1 (Fusobacterium/oral pathogens, proteolytic, 21%), right-sided, high-grade, MSI-high, CIMP-positive, CMS1, BRAF V600E, and FBXW7 mutated; OCS2 (Firmicutes/Bacteroidetes, saccharolytic, 44%), and OCS3 (Escherichia/Pseudescherichia/Shigella, fatty acid β-oxidation, 35%) both left-sided and exhibiting CIN. OCS1 was associated with MSI-related mutation signatures (SBS15, SBS20, ID2, and ID7) and OCS2 and OCS3 with SBS18 related to damage by reactive oxygen species. Among stage II/III patients, OCS1 and OCS3 both had poorer overall survival compared with OCS2 for microsatellite stable tumors (multivariate hazard ratio [HR], 1.85; 95% confidence interval [CI], 1.15-2.99; P = .012; and HR, 1.52; 95% CI 1.01-2.29; P = .044, respectively) and left-sided tumors (multivariate HR, 2.66; 95% CI, 1.45-4.86; P = .002; and HR, 1.76; 95% CI, 1.03-3.02; P = .039, respectively). CONCLUSIONS: OCS classification stratified CRCs into 3 distinct subgroups with different clinicomolecular features and outcomes. Our findings provide a framework for a microbiota-based stratification of CRC to refine prognostication and to inform the development of microbiota-targeted interventions.
引用
- Mouradov D, Greenfield P, Li S, et al. Oncomicrobial Community Profiling Identifies Clinicomolecular and Prognostic Subtypes of Colorectal Cancer. Gastroenterology. 2023. PMID: 36933623. doi:10.1053/j.gastro.2023.03.205
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。